Effect Whole Body Vibration on Balance in Post Diabetic Menopause Women

What this trial studies

Postmenopausal diabetic women have significant balance deficits and increased fall risk. Whole-body vibration may improve balance in these population but needs further research. The purpose of the current study was to determine the effect of whole-body vibration on balance in postmenopausal diabetic women.

Conditions in scope

• Diabetic Peripheral Neuropathy
• Postmenopausal Women

Interventions

• Whole body vibration (Other) — All women in group (A) received whole body vibration and balance board training, three times per week for three months. Parameters: The WBV was performed by using whole body vibration which is a side-alternating vibration device working as a teeterboard…
• Balance training (Other) — Balance training exercises treatment: All women in both group (A, B) received balance training exercises on balance ball, half ball and balance board exercises three times per week for 3 months

Who can join

Women only · Ages 50 Years to 65 Years

Inclusion criteria

• Patients were examined by a gynaecologist before the study and were selected according to the following criteria:
• Diabetic postmenopausal women who suffered from peripheral neuropathy
• Their ages ranged from 50 to 65 years.
• Body Mass Indices (BMI) ≤ 30kg/m2
• They were medically stable.

Exclusion criteria

• Patients were examined by a gynaecologist before the study and were excluded if they had:
• Inner ear disturbance.
• Musculoskeletal problems.
• Active tuberculosis and tumours.
• Implanted cardiac rhythm devices.
• Any hormonal replacement therapy or drug treatment that could affect normal metabolism of musculoskeletal system.
• Habitual exercise or participate in any supervised exercise.
• Hypo- or hyperparathyroidism, renal, liver, or chronic disease.

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Interventional
• Phase: N/A
• Start date: 2024-05-28
• Primary completion: 2025-01-01
• Last update posted: 2025-04-20
• First posted: 2025-04-20

Sponsor & contact

Lead sponsor: Cairo University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• OSI (pre and after 3 months of intervention)
  TThe BBS measures, in degrees, the tilt about each axis during dynamic conditions and calculates a medial-lateral stability index (MLSI), anterior-posterior stability index (APSI), and an overall stability index (OSI). The OSI score is believed to be the best indicator of the overall ability.

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.